BioSpace News Archive

Biotech Bay

Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center

Varian proton therapy systems to now be installed in two Penn Medicine centers

October 23, 2019
·
2 min read
Deals

ICON’s Acquisition of Symphony Clinical Research

Acquisition enhances ICON’s ability to offer customers hybrid trial solutions and site support services

October 23, 2019
·
4 min read
Deals

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct. 23, 2019

PTC Therapeutics, Inc. announced that on October 18, 2019 it approved non-statutory stock options to purchase an aggregate of 144,150 shares of its common stock to 29 new employees.

October 23, 2019
·
1 min read
Deals

Charles River Laboratories Announces Closing of Senior Notes Offering - Oct. 23, 2019

Charles River Laboratories International, Inc. announced that it has closed its previously announced offering of $500 million in aggregate principal amount of its 4.25% senior notes due 2028 in an unregistered offering.

October 23, 2019
·
3 min read
Business

bluebird bio Announces Transition of Chief Strategy Officer Jeffrey T. Walsh

Jeffrey T. Walsh, chief strategy officer, has decided to transition from his current role effective January 6, 2020.

October 23, 2019
·
4 min read
Biotech Beach

Mirati Therapeutics Announces Presentation Of Interim Phase 2 Sitravatinib Data In Urothelial Carcinoma And Oral Cavity Squamous Cell Carcinoma At The SITC 34th Annual Meeting

Company will have two presentations at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting on November 6-10, 2019 at the Gaylord National Convention Center in National Harbor, MD.

October 23, 2019
·
5 min read
Business

TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results

Company estimates that its consolidated net revenue from its prescription vitamin business will range from approximately $2.50 million to $2.60 million

October 23, 2019
·
6 min read
Business

TherapeuticsMD Announces Proposed Underwritten Public Offering of 22 Million Shares of Common Stock

The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

October 23, 2019
·
4 min read
Kanaph Therapeutics Raises 6M USD in Series A Financing - “Large and Small Molecule Drug Development in Immuno-Oncology”

Participation from Timefolio Asset Management and Meritz Securities – To cure solid tumors with its tumor microenvironment(TME)-targeting immunocytokine platform, TMEkineTM

October 23, 2019
·
1 min read
Business

Study Investigates Effects of Masimo SpHb®, Noninvasive and Continuous Hemoglobin Monitoring, on Postoperative Anemia and Inappropriate Blood Transfusion in Patients Undergoing Hip and Knee Surgery

Masimo announced the findings of an abstract recently presented at the American Society of Anesthesiologists 2019 Annual Meeting.

October 23, 2019
·
8 min read